Although IBM has proved to be refractory to corticosteroids and some other immunosuppressants, this may be due to the durable nature of highly differentiated CD8+ T cells in evading cell death mechanisms, and they may be more susceptible to more targeted therapeutics[5]. This evidence concerns the gene CD8A and inclusion body myositis.